Biocom advocates on behalf of our members to advance positions and policies that support the life science sector.
Biocom drives Policy & Advocacy initiatives on behalf of the California life science industry. Since its founding in 1995, Biocom has emerged as the most respected association voice in regional government, the State Capitol, and Washington, D.C. Our member committees determine positions to encourage public officials to pass legislation that is positive to the California life science industry, while working to defeat proposals that would be detrimental.
Biocom’s Federal Policy & Advocacy team advocates on behalf of our members to support funding for federal agencies that drive research and approve new products, a fair reimbursement and pricing landscape to ensure that patients have access to much-needed medicines, research and pandemic preparedness to prevent future outbreaks, strong IP protections to allow innovators to get a return on their investments; a business friendly-tax environment that allow businesses to strive and grow; and expand loan guarantees and grants to access capital for ag and energy biotech.
Biocom advocates for a competitive regulatory environment that protects investment in new therapies and access for our patients. Our policy priorities across the state of California include a wide range of issues from public health, access to new therapies, and information stewardship practices. We advocate for improved infrastructure, safe and reliable water supplies, and critical public interest policies to support innovation.
Our priorities in the Bay Area region include accessibility and reliability of utilities, reducing business tax burdens where appropriate, and advancing land use proposals to facilitate future life science developments. We also engage on traditional business issues, such as advocating for more seamless transit infrastructure and the availability of middle-income housing.
Learn More →
Our priorities in the greater Los Angeles region include identifying land for future life science developments, accessibility and reliability of utilities, and reducing business tax burdens where appropriate. We also engage on traditional business issues such as enhancing transit systems and availability of middle-income housing.
Learn More →
Biocom was founded in San Diego in 1995 around the issue of access to water, and we continue to advocate for consistent, reliable utilities needed in delicate research processes. We assist members with all local permitting and inspection matters, and advocate for infrastructure improvements including storm channels, transit networks, and middle-income housing.
Learn More ↗Calendar
Designed by life science CEOs, exclusively for industry CEOs, in San Diego, the Bay Area and Greater Los Angeles.
An exclusive evening of connection and collaboration during The MedTech Conference in Boston.
The partnering and investor forum for the global life science community. Applications to present are open until November 13.
Biocom committees bring together policy experts to discuss new legislative and regulatory developments and shape our policy positions at the federal, state and local levels. With over twelve committees, such as Regulatory Affairs, Environmental Health and Safety, Intellectual Property, and Facilities, Biocom’s Public Policy related committees are an ideal way for members to affect change in the areas that matter most to them.
Finding federal funding is time-intensive and fragmented across agencies. Provided complimentary to Biocom members, the Government Bioscience Grants (GBG) Report is a comprehensive monthly briefing of opportunities across NIH, DoD, DOE, BARDA and ARPA-H that enables life science R&D companies to focus on applying instead of searching. Access to this report is valued at $1,000 annually.
Each monthly report includes:
Customize your newsletter subscriptions to receive only the public policy news that is most relevant to you.
Monthly newsletter featuring the latest federal, state (California) and regional (San Diego, Los Angeles, Bay Area) affairs. Receive notifications on upcoming events.
View Archived →Receive monthly policy updates regarding regulatory & reimbursement news, related events, and opportunities to provide comments.
View Archived →
Zoe KosmidisSr Regulatory Policy ManagerBiocom
Emily CasselGovernment Affairs Events & Projects ManagerBiocom
Laure ClarkSr Director, Federal Policy & Government AffairsBiocom
Melanie CohnSr Director, Regional Policy & Government AffairsBiocom
Claire ConlonSr Director, State Government AffairsBiocom
Jimmy JacksonSr VP & Chief Policy OfficerBiocom
Megan KastnerFederal Advocacy ManagerBiocom
Gilbert LaraManager, State Government AffairsBiocom
Christy ShirillaPolicy ManagerBiocomIn this section
Federal Policy & AdvocacyBiocom works alongside legislators and regulators to drive innovation and advance federal policy priorities.
Los Angeles Policy & AdvocacyIn the greater Los Angeles region, we advocate for land use and zoning policies that identify areas for future life science developments…
Policy Champion – Chad Augustin, Fire Chief, City of PasadenaChad Augustin joined the City of Pasadena as its new fire chief in February 2021 from the Sacramento Fire Department where he worked for…
Policy Champion – Dr. Julianne McCall, Director of Precision MedicineSeth Litchney is the program manager for housing policy with the City of San Diego’s Planning Department.
Policy Champion – Elizabeth Redman Cleveland, Chief Strategist for Sustainable Growth, City of Berkeley's Office of Economic DevelopmentElizabeth Redman Cleveland led Berkeley in changing its land use definition of R&D in 2022, making it more inclusive to reflect the work…
Policy Champions - Greater Los Angeles Policy Committee Co-ChairsThis month's Policy Champion are committee co-chairs Julia Bradsher from Huntington Medical Research Institute and Matthew Welsh from Lun…
Policy Champions - Regulatory Affairs Committee Co-ChairsThis month's Policy Champion are committee co-chairs Scott Cunningham of Covington & Burling and Jennifer Shen of ORIC Pharmaceuticals.
Policy Champions - San Diego Facilities Committee Co-ChairsThis month's Policy Champion are committee co-chairs Jason Moorhead of Alexandria Real Estate Equities, Laura Hale of Veracyte Labs, and…
Policy Champion – Seth Litchney, Program Manager for Housing Policy, City of San DiegoSeth Litchney is the program manager for housing policy with the City of San Diego’s Planning Department.
Regulatory PolicyBiocom’s Federal, State and Regional Policy teams advocate for policies that create a positive regulatory environment for California’s li…
San Diego Policy & AdvocacyBiocom advocates for consistent, reliable utilities needed in research processes, assists members with local permitting and inspections,…Biocom State Life Science AdvocacyBiocom is committed to improving public policies to better the life science industry where innovation can thrive.
Why R&D Tax Changes Are Hurting America’s Biotech IndustryUrge your Senator to cosponsor the Tax Relief for American Families and Workers Act of 2024 (H.R. 7024) today to protect the domestic dev…